U31402-A-U102
ClinicalTrials.gov NCT03260491
Research payments
$8,413,983
Through program year 2025, $8,413,983 in research payments was reported against U31402-A-U102, across 2,095 payments, paid by Daiichi Sankyo Inc..
- Paid by
- Daiichi Sankyo Inc.
- ClinicalTrials.gov
- NCT03260491
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $442,209 | 389 |
| 2024 | Research | $697,401 | 174 |
| 2023 | Research | $1,331,240 | 268 |
| 2022 | Research | $914,401 | 560 |
| 2021 | Research | $2,196,759 | 570 |
| 2020 | Research | $1,678,894 | 42 |
| 2019 | Research | $1,153,079 | 92 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
5 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.